[1]
Dr.Vino Anand S et al. 2024. SAFETY PROFILE OF PALBOCICLIB IN ELDERLY PATIENTS WITH HORMONE RECEPTOR-POSITIVE/HER2 NEGATIVE METASTATIC BREAST CANCER: REGIONAL CANCER CENTER EXPERIENCE IN SOUTH INDIA. Journal of Population Therapeutics and Clinical Pharmacology. 31, 10 (Oct. 2024), 469–473. DOI:https://doi.org/10.53555/fyxdh871.